Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Event: ESC Asia 2022 with APSC & AFC
Topic: Cardiovascular Pharmacotherapy
Session: Pharmacology and Pharmacotherapy
Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Chronic heart failure treatment
Efficacy of sodium glucose cotransporter-2 inhibitors for heart failure with preserved and with mildly reduced ejection fraction: a systematic review and meta-analysis
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Heart Failure ePosters - focus on Chronic Heart Failure 3
ESC 365 is supported by
